Evidence map›Paper›PMID 41721156›Full record

ArticleNeurogenetics2026

Compound heterozygosity of a novel missense variant and exonic deletion in hypomyelinating leukodystrophy 15.

Akihiko Mitsutake, Takashi Matsukawa, Kenta Orimo, Kunihiro Ueda, Tomonari Seki, Yasushi Shiio, Jun Mitsui, Hiroyuki Ishiura, Harushi Mori, Shoji Tsuji and 1 more

Abstract readCase Reports
In one paragraph

Article in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akihiko MitsutakeDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takashi MatsukawaDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. matsukawat-int@h.u-tokyo.ac.jp.
Kenta OrimoDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kunihiro UedaDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tomonari SekiDepartment of Neurology, Tokyo Teishin Hospital, Tokyo, Japan.
Yasushi ShiioDepartment of Neurology, Tokyo Teishin Hospital, Tokyo, Japan.
Jun MitsuiDepartment of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki IshiuraDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Harushi MoriDepartment of Radiology, School of Medicine, Jichi Medical University, Tochigi, Japan.
Shoji TsujiInstitute of Medical Genomics, International University of Health and Welfare, Chiba, Japan.
Tatsushi TodaDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypomyelinating leukodystrophy 15 (HLD15) results from biallelic pathogenic variants in EPRS1, but exonic deletions have not been reported. We describe a 40-year-old woman with mild intellectual disability, ataxia, dystonia, and MRI showing hypomyelination. Whole-exome sequencing identified a heterozygous missense variant in the prolyl-tRNA synthetase domain of EPRS1 (c.3430 C > G; p.Leu1144Val, NM_004446.3), without second variant. Whole-genome sequencing revealed a heterozygous 220-bp deletion spanning exon 15 (c.1743-30_1932del), and segregation analysis confirmed compound heterozygosity. RT-PCR from lymphoblastoid cells demonstrated exon-15 skipping leading to a frameshift (p.Asn582Serfs*10) and nonsense-mediated decay, leaving predominant expression of the paternally inherited missense allele. These findings support loss-of-function for the deletion and classify c.3430 C > G as likely pathogenic under ACMG/AMP criteria (PM1, PM2, PM3, PP3). This case represents the first exonic deletion reported in EPRS1. The relatively mild, adult-onset phenotype broadens both mutational and clinical spectra of HLD15 and highlights the importance of structural-variant analysis when only a single candidate variant is detected in recessive leukodystrophy.

Indexed as

Amino Acyl-tRNA SynthetasesHereditary Central Nervous System Demyelinating DiseasesMutation, MissenseSequence DeletionAdultExonsFemaleHeterozygoteHumansAmino Acyl-tRNA SynthetasesEPRS1Exon deletionHypomyelinating leukodystrophyNonsense‑mediated decayStructural variantWhole‑genome sequencing

Identifiers

PMID41721156
PMCPMC12923470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.